Loading...
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
BACKGROUND: Despite major advances in transplant medicine, improvements in long-term kidney allograft survival have not been commensurate with those observed shortly after transplantation. The formation of donor-specific antibodies (DSA) and ongoing antibody-mediated rejection (AMR) processes may cr...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014747/ https://ncbi.nlm.nih.gov/pubmed/24708575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-107 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|